Why Is CLOVER HEALTH INVTS A (CLOV) Stock Moving Today?

Clover Health Investments stock rose 10.59% to $5.07 on Thursday, driven by a new five-star rating from the Centers for Medicare & Medicaid Services. The designation for the company’s wide-network PPO Medicare Advantage plans allows for year-round beneficiary enrollment, a significant operational improvement for the insurer.

What Happened

Clover Health announced that CMS awarded its PPO Medicare Advantage plans a five-star rating for 2027, which affects the 2028 payment year. This top-tier rating is a key driver for enrollment growth and potential bonus payments. The company filed a Form 8-K with the SEC on October 9, 2026, disclosing the regulatory update and accompanying financial statements. The stock had already gained 9.4% over the previous eight sessions, moving from $4.24 to $4.64, before this latest catalyst.

What The Data Shows

The stock opened at $5.04, representing a 10.0% gap up from the prior close of $4.58. Intraday trading saw the price reach a session high of $5.20 at 9:25 AM ET and a low of $4.96 at 9:30 AM ET. Volume stood at 1.1 million shares, which is 0.2 times the three-month daily average. Clover Health has a market capitalization of $2.4 billion and remains unprofitable with a trailing twelve-month EPS of negative $0.04. Revenue grew 54.0% over the trailing twelve months, though the net margin is negative 0.7%. The stock’s beta is 2.46, indicating high volatility relative to the market. The 52-week range is $1.58 to $5.59, and the stock printed a fresh 52-week low on October 9, 2026. Insider activity has been notable, with 18 sales totaling $4.3 million in the last 90 days and no purchases. Recent sales include transactions by CEO Andrew Toy on October 1 and Jamie L. Reynoso, CEO of Medicare Advantage, on October 5 and 7.

What To Watch

Clover Health is scheduled to report its third quarter 2026 financial results on November 4, 2026. Investors will look for details on how the new star rating impacts enrollment trends and revenue projections during the upcoming earnings call.

Why is CLOV stock moving today?

CLOVER HEALTH INVTS A (CLOV) is drawing unusual attention today. Our newswire has captured 1 story on CLOV across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 50/100). The most recent driver: "Clover Health Investments, Corp. 2026 Q3 - Results - Earnings Call Presentation" (Seeking Alpha).

Is CLOV a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of CLOV coverage reads 50/100 over 1 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.